These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8403248)

  • 1. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z; Wolf MB
    Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.
    Perico N; Delaini F; Tagliaferri M; Abbate M; Cucchi M; Bertani T; Remuzzi G
    Lab Invest; 1988 Feb; 58(2):163-71. PubMed ID: 3123798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
    Stock EL; Roth SI; Kim ED; Walsh MK; Thamman R
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):987-92. PubMed ID: 2335460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of microvascular hydraulic permeability by platelet-activating factor.
    Victorino GP; Newton CR; Curran B
    J Trauma; 2004 Feb; 56(2):379-84. PubMed ID: 14960983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rolipram and isoproterenol reverse platelet activating factor-induced increases in pulmonary microvascular permeability and vascular resistance.
    Noel PE; Fletcher JR; Thompson WJ
    J Surg Res; 1995 Jul; 59(1):159-64. PubMed ID: 7630121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute microcirculatory effects of platelet-activating factor.
    Durán WN; Dillon PK
    J Lipid Mediat; 1990; 2 Suppl():S215-27. PubMed ID: 2133284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activating factor and histamine effects in synovial blood flow evaluated by laser-Doppler flowmetry.
    Rocha FA; Jancar S; Fraga CA; Timo-Iaria C; De Brum-Fernandes AJ
    J Rheumatol; 1993 Aug; 20(8):1374-7. PubMed ID: 8230022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor.
    Zhang Y; Gu Y; Lucas MJ; Wang Y
    J Soc Gynecol Investig; 2003 Jan; 10(1):5-10. PubMed ID: 12517587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of platelet activating factor (PAF) in histamine-induced model of nasal allergy in rats.
    Akagi M; Kanoh R; Fukuishi N; Tachibana M; Akagi R
    Arerugi; 1995 Mar; 44(3 Pt 1):182-8. PubMed ID: 7646374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
    Brkovic A; Sirois MG
    J Cell Biochem; 2007 Feb; 100(3):727-37. PubMed ID: 17115409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
    Felix SB; Baumann G; Hashemi T; Niemczyk M; Ahmad Z; Berdel WE
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):987-97. PubMed ID: 1694923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC; Szpejda M
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
    Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
    Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.
    Ramirez R; Chong T; Victorino GP
    J Surg Res; 2006 Aug; 134(2):259-64. PubMed ID: 16515797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.